These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28701643)

  • 1. [GUIDE TO ALLERGEN IMMUNOTHERAPY FOR MITE ALLERGY].
    Gotoh M
    Arerugi; 2017; 66(6):788-791. PubMed ID: 28701643
    [No Abstract]   [Full Text] [Related]  

  • 2. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 3. Worldwide allergen immunotherapy guidelines: Evidence and experience-based.
    Larenas-Linnemann DES
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():17-22. PubMed ID: 29108768
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE OFFICIAL HAND BOOK FOR ALLERGEN IMMUNOTHERAPY IN MITE-ALLERGY - CAUSAL TREATMENT FOR PERENNIAL ALLERGIC AIRWAY DISEASES].
    Nagata M
    Arerugi; 2016 Jul; 65(7):908-12. PubMed ID: 27545055
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of desensitization via the sublingual route in mite allergy.
    Guez S
    Chem Immunol Allergy; 2003; 82():62-76. PubMed ID: 12947993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What should drive the choice of allergen for immunotherapy in polysensitized patients?
    Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259
    [No Abstract]   [Full Text] [Related]  

  • 7. Sublingual immunotherapy: other indications.
    Passalacqua G; Compalati E; Canonica GW
    Immunol Allergy Clin North Am; 2011 May; 31(2):279-87, ix. PubMed ID: 21530820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic aspects in house dust mite allergy.
    Mosbech H
    Dan Med Bull; 1991 Oct; 38(5):390-400. PubMed ID: 1802624
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of allergoid immunotherapy: is cat allergy a suitable target?
    Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R
    Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.
    Takai T; Yokota T; Yasue M; Nishiyama C; Yuuki T; Mori A; Okudaira H; Okumura Y
    Nat Biotechnol; 1997 Aug; 15(8):754-8. PubMed ID: 9255789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparing and mixing allergen vaccines for subcutaneous immunotherapy.
    Nelson HS
    Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New?
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):1-14. PubMed ID: 31761112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EAACI Allergen Immunotherapy User's Guide.
    Alvaro-Lozano M; Akdis CA; Akdis M; Alviani C; Angier E; Arasi S; Arzt-Gradwohl L; Barber D; Bazire R; Cavkaytar O; Comberiati P; Dramburg S; Durham SR; Eifan AO; Forchert L; Halken S; Kirtland M; Kucuksezer UC; Layhadi JA; Matricardi PM; Muraro A; Ozdemir C; Pajno GB; Pfaar O; Potapova E; Riggioni C; Roberts G; Rodríguez Del Río P; Shamji MH; Sturm GJ; Vazquez-Ortiz M
    Pediatr Allergy Immunol; 2020 May; 31 Suppl 25(Suppl 25):1-101. PubMed ID: 32436290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular-allergological aspects of allergen-specific immunotherapy].
    Jappe U
    Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE OFFICIAL MANUAL BOOK ON ALLERGEN-IMMUNOTHERAPY IN HOUSE-DUST-MITE ALLERGY].
    Nagata M
    Arerugi; 2019; 68(3):146-150. PubMed ID: 31105110
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergen injection immunotherapy.
    Varga EM; Durham SR
    Clin Allergy Immunol; 2002; 16():533-49. PubMed ID: 11577558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.